[{"NetIncomeLoss_1_Q1_USD":5694000.0,"ConvertibleLongTermNotesPayable_0_Q1_USD":366038000.0,"DepreciationAndAmortization_1_Q1_USD":600000.0,"AccruedRoyaltiesCurrent_0_Q1_USD":10635000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":70099000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":14909000.0,"InterestPaidNet_1_Q1_USD":1258000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":6249000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-71445000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":2247000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":646000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":70099000.0,"AssetsCurrent_0_Q1_USD":586023000.0,"MarketableSecuritiesCurrent_0_Q1_USD":135459000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":1269504.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":61457000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":18499000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":14954000.0,"FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_0_Q1_USD":22747000.0,"ResearchAndDevelopmentInProcess_1_Q1_USD":15000000.0,"IncomeTaxesPaidNet_1_Q1_USD":301000.0,"CommonStockSharesIssued_0_Q1_shares":52994137.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":9330000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":552025000.0,"Assets_0_Q1_USD":1507443000.0,"ShareBasedCompensation_1_Q1_USD":4371000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":20808000.0,"OtherNoncashIncomeExpense_1_Q1_USD":1202000.0,"InterestExpenseOther_1_Q1_USD":1035000.0,"Liabilities_0_Q1_USD":752999000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":255642000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":40244000.0,"EarningsPerShareBasic_1_Q1_USD":0.11,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-2726000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":54196971.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":3812000.0,"AccountsReceivableNetCurrent_0_Q1_USD":127065000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":5235000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_1_Q1_USD":1706000.0,"CommonStockValue_0_Q1_USD":53000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded_1_Q1_USD":0.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-10008000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":6592000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":28532000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1_Q1_USD":1020000.0,"OtherSundryLiabilitiesNoncurrent_0_Q1_USD":9413000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":2247000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_0_Q1_USD":52621000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":1020000.0,"CostsAndExpenses_1_Q1_USD":117718000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":49579000.0,"IncreaseDecreaseInInventories_1_Q1_USD":1048000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":5694000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":2968000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":6007000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_0_Q1_USD":14671000.0,"OtherAssetsNoncurrent_0_Q1_USD":30257000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.479,"ResearchAndDevelopmentExpense_1_Q1_USD":34280000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":2247000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0_Q1_USD":37950000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":4371000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":36200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":52927467.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q1_USD":31520000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":135459000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":416566000.0,"LiabilitiesCurrent_0_Q1_USD":240812000.0,"AccountsPayableCurrent_0_Q1_USD":5954000.0,"NonoperatingIncomeExpense_1_Q1_USD":-2285000.0,"InterestExpense_1_Q1_USD":6097000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":255642000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":17631000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":10929000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":10640000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":5744000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":358736000.0,"MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_1_Q1_USD":216000.0,"AdditionalPaidInCapital_0_Q1_USD":415950000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":453000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q1_USD":80.9063,"AdvertisingExpense_1_Q1_USD":15300000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"OperatingLeasePayments_1_Q1_USD":1834000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":31742000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":46200000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":37950000.0,"InterestExpenseDebt_1_Q1_USD":5062000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"Goodwill_0_Q1_USD":77911000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-2726000.0,"CommonStockSharesAuthorized_0_Q1_shares":130000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":130932000.0,"OperatingIncomeLoss_1_Q1_USD":13214000.0,"InventoryNet_0_Q1_USD":50226000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q1_USD":77720000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-2565000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1507443000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":13080000.0,"InventoryWorkInProcessAndRawMaterialsNetOfReserves_0_Q1_USD":25987000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":4371000.0,"FinanceLeaseRightOfUseAsset_0_Q1_USD":20071000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":4242000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":8958000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":39675000.0,"OtherLiabilitiesCurrent_0_Q1_USD":10457000.0,"StockholdersEquity_0_Q1_USD":754444000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1508000.0,"UnrealizedGainLossOnDerivatives_1_Q1_USD":-1020000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":543713000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":4287000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":332192000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-32998000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-13805000.0,"CommonStockSharesOutstanding_0_Q1_shares":52868482.0,"EarningsPerShareDiluted_1_Q1_USD":0.11,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":119063000.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":4677000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":4524000.0,"Ticker":"SUPN","CIK":"1356576","name":"SUPERNUS PHARMACEUTICALS, INC.","OfficialName":"Supernus Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1557812380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210507"}]